Our R&D Approach
Cancer is clever, but we’re plotting new approaches to outsmart it with a goal to profoundly impact patients’ lives. Patients with limited or ineffective treatment options motivate us every day. We are committed to outsmarting cancer so that more patients can benefit from – and have access to – life-transforming medicines.
For decades, Takeda Oncology has led in the development of targeted therapies for hematologic malignancies. Our pipeline builds on that foundation with treatments in development for blood and solid cancers.
While cancer is clever, we know the immune system is too. Through our cancer research and development, we’re building upon our deep understanding of cancer to develop new ways to harness specific cells within the immune system, known as innate immune cells.